Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

Phase 2

6(75.0%)

N/A

2(25.0%)

8Total

Phase 2(6)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07060508Phase 2Recruiting

L9LS in Women of Childbearing Potential in Mali

Role: collaborator

NCT05304611Phase 2Completed

Anti-malaria MAb in Malian Children

Role: collaborator

NCT05816330Phase 2Completed

L9LS MAb in Malian Adults

Role: collaborator

NCT01614964Phase 2Completed

Studies of a Candidate Aminoquinoline Antimalarial (AQ-13)

Role: collaborator

NCT04940130Phase 2Completed

PfSPZ Vaccine Trial in Malian Children

Role: collaborator

NCT05248516Phase 2Unknown

ComPAS Low-WAZ RCT Mali

Role: collaborator

NCT03303963Completed

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

Role: collaborator

NCT03656237Not ApplicableCompleted

Low-dose High-frequency Training of Facility Health Care Providers in Mali

Role: collaborator

NCT02557373Not ApplicableCompleted

Pilot Feasibility of Rice Bran Supplementation in Children

Role: collaborator

All 9 trials loaded